Literature DB >> 21564386

Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty.

Stephanie R Johnson1, Richard C Nolan, Maree T Grant, Glynis J Price, Aris Siafarikas, Lewis Bint, Catherine Sy Choong.   

Abstract

We describe a case of an 8 year old girl with central precocious puberty. She was commenced on 3 monthly intramuscular depot Leuprorelin acetate therapy, as a result of which she developed sterile abscesses. She was converted to daily subcutaneous Leuprorelin acetate therapy with no recurrence of the abscesses. The possible mechanisms for this reaction are described in the article.
© 2011 The Authors. Journal of Paediatrics and Child Health © 2011 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21564386     DOI： 10.1111/j.1440-1754.2011.02083.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN： 1034-4810            Impact factor:   1.954


  7 in total

Review 1.  Is surgery effective for treating hypothalamic hamartoma causing isolated central precocious puberty? A systematic review.

Authors:  Mohit Agrawal; Raghu Samala; Ramesh Sharanappa Doddamani; Alpesh Goyal; Manjari Tripathi; Poodipedi Sarat Chandra
Journal:  Neurosurg Rev       Date:  2021-02-28       Impact factor: 3.042

2.  Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty.

Authors:  Ji Woo Lee; Hyung Jin Kim; Yun Mee Choe; Hee Suk Kang; Soon Ki Kim; Yong Hoon Jun; Ji Eun Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-09-30

Review 3.  Diagnosis and management of precocious sexual maturation: an updated review.

Authors:  Amanda Veiga Cheuiche; Leticia Guimarães da Silveira; Leila Cristina Pedroso de Paula; Iara Regina Siqueira Lucena; Sandra Pinho Silveiro
Journal:  Eur J Pediatr       Date:  2021-03-21       Impact factor: 3.183

4.  Postinjection Muscle Fibrosis from Lupron.

Authors:  Erica Everest; Laurie A Tsilianidis; Nouhad Raissouni; Tracy Ballock; Terra Blatnik; Anzar Haider; Douglas G Rogers; B Michelle Schweiger
Journal:  Case Rep Pediatr       Date:  2015-05-25

5.  Evaluation of Hypersensitivity Reactions with Leuprolide Acetate and Triptorelin Acetate in Children.

Authors:  Azize Pınar Metbulut; Keziban Toksoy Adıgüzel; Candan İslamoğlu; Mehmet Boyraz; Emine Dibek Mısırlıoğlu
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17

Review 6.  Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States.

Authors:  Jadranka Popovic; Mitchell E Geffner; Alan D Rogol; Lawrence A Silverman; Paul B Kaplowitz; Nelly Mauras; Philip Zeitler; Erica A Eugster; Karen O Klein
Journal:  Front Pediatr       Date:  2022-10-04       Impact factor: 3.569

Review 7.  Pros and cons of GnRHa treatment for early puberty in girls.

Authors:  Ruben H Willemsen; Daniela Elleri; Rachel M Williams; Ken K Ong; David B Dunger
Journal:  Nat Rev Endocrinol       Date:  2014-04-08       Impact factor: 43.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.